
Overview
Dan P. Zandberg, MD, is an associate professor of medicine and a medical oncologist/hematologist, specializing in the treatment of head and neck and thyroid cancers. He is the Director of the Head and Neck and Thyroid Cancer disease sections for the division of Hematology/Oncology and the Medical Oncology Co-Leader of the UPMC Hillman Head and Neck Cancer Program. He is also the physician lead for the second floor Hillman Cancer Center clinic. His main research focus is in the development of clinical trials with immunotherapy to improve patient outcomes. Recent awards include the 2019 National Cancer Institute (NCI) Cancer Clinical Investigator Team Leadership Award, 2020 Leo Criep, M.D. Excellence in Patient Care Award, and 2020/2021 Castle Connolly Regional Top Doctor.
Dr. Zandberg is highly rated in 22 conditions, according to our data. His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Oral Squamous Cell Carcinoma, Small Cell Lung Cancer (SCLC), and ALK-Positive Non-Small Cell Lung Cancer.
His clinical research consists of co-authoring 66 peer reviewed articles and participating in 29 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MEDICARE PART D
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- MANAGED MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
5115 Centre Avenue, Hillman Cancer Center, Pittsburgh, PA 15232
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
29 Clinical Trials
UPMC Hillman Cancer Center
Melissa Burgess, MD, is an assistant professor at the University of Pittsburgh School of Medicine and a medical oncologist. She specializes in the treatment of soft tissue and bone sarcomas and Merkel cell carcinoma. Dr. Burgess is highly rated in 42 conditions, according to our data. Her top areas of expertise are Adult Soft Tissue Sarcoma, Merkel Cell Carcinoma, Liposarcoma, Chondrosarcoma, and Gamma Knife Radiosurgery.
UPMC Hillman Cancer Center
Liza C. Villaruz, MD, is board-certified in medical oncology and hematology at UPMC Hillman Cancer Center, and she specializes in lung cancer and thoracic malignancies. Dr. Villaruz is highly rated in 13 conditions, according to our data. Her top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, and Small Cell Lung Cancer (SCLC).
UPMC Hillman Cancer Center
Adam M. Brufsky, MD, PhD, FACP, is professor of medicine at the University of Pittsburgh School of Medicine and also serves as the associate division chief for the Division of Hematology/Oncology at the University of Pittsburgh School of Medicine's Department of Medicine. Dr. Brufsky is the medical director of the Magee-Women's Cancer Program, part of the UPMC Hillman Cancer Center, and UPMC Hillman Cancer Center; associate director for clinical investigations at UPMC Hillman Cancer Center; and codirector of the Comprehensive Breast Cancer Center. Dr. Brufsky is board-certified in internal medicine and medical oncology. He earned a medical and doctor of philosophy degrees from the University of Connecticut School of Medicine in Farmington, Conn.; completed a residency at Brigham and Women's Hospital, Harvard Medical School, and a fellowship at Dana-Farber Cancer Institute. Dr. Brufsky is a member of professional organizations, such as American Medical Association, Massachusetts Medical Society, American College of Physicians, American Society of Clinical Oncology, American Association for Cancer Research, Allegheny County Medical Society, Pennsylvania Medical Society, and Pennsylvania Oncologic Society. An active researcher, Dr. Brufsky has numerous abstracts and research articles in leading journals, and is principal investigator on a number of research grants funded by the National Institutes of Health, Susan G. Komen Foundation, and US Army - Breast Cancer Research Program. Dr. Brufsky is highly rated in 14 conditions, according to our data. His top areas of expertise are Breast Cancer, Triple-Negative Breast Cancer, Inflammatory Breast Cancer, Paget Disease of the Breast, and Gastrostomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- Distinguished
- Adenoid Cystic CarcinomaDr. Zandberg isDistinguished. Learn about Adenoid Cystic Carcinoma.
- ALK-Positive Non-Small Cell Lung CancerDr. Zandberg isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Oral Squamous Cell CarcinomaDr. Zandberg isDistinguished. Learn about Oral Squamous Cell Carcinoma.
- Pleuropulmonary BlastomaDr. Zandberg isDistinguished. Learn about Pleuropulmonary Blastoma.
- Small Cell Lung Cancer (SCLC)Dr. Zandberg isDistinguished. Learn about Small Cell Lung Cancer (SCLC).
- Squamous Cell Lung CarcinomaDr. Zandberg isDistinguished. Learn about Squamous Cell Lung Carcinoma.
- Advanced
- Acinic Cell Carcinoma of Salivary Glands
- EGFR Positive Lung CancerDr. Zandberg isAdvanced. Learn about EGFR Positive Lung Cancer.
- GliomaDr. Zandberg isAdvanced. Learn about Glioma.
- Large-Cell Lung CarcinomaDr. Zandberg isAdvanced. Learn about Large-Cell Lung Carcinoma.
- Laryngeal CancerDr. Zandberg isAdvanced. Learn about Laryngeal Cancer.
- Lung AdenocarcinomaDr. Zandberg isAdvanced. Learn about Lung Adenocarcinoma.
- Experienced
- Acute Myeloid Leukemia (AML)Dr. Zandberg isExperienced. Learn about Acute Myeloid Leukemia (AML).
- AgranulocytosisDr. Zandberg isExperienced. Learn about Agranulocytosis.
- Anaplastic Thyroid CancerDr. Zandberg isExperienced. Learn about Anaplastic Thyroid Cancer.
- Bone TumorDr. Zandberg isExperienced. Learn about Bone Tumor.
- Cholangiocarcinoma (Bile Duct Cancer)Dr. Zandberg isExperienced. Learn about Cholangiocarcinoma (Bile Duct Cancer).
- Chronic Familial NeutropeniaDr. Zandberg isExperienced. Learn about Chronic Familial Neutropenia.



